Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Capital Expenditures (2016 - 2025)

INVO Fertility (IVF) has disclosed Capital Expenditures for 10 consecutive years, with $8062.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to $8062.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $110463.0, a 38.57% decrease, with the full-year FY2024 number at $183703.0, down 58.69% from a year prior.
  • Capital Expenditures was $8062.0 for Q3 2025 at INVO Fertility, down from $8877.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $108217.0 in Q3 2023 to a low of -$328537.0 in Q4 2021.
  • A 5-year average of $6212.1 and a median of $8877.0 in 2025 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: tumbled 1243.41% in 2021, then skyrocketed 55655.56% in 2023.
  • INVO Fertility's Capital Expenditures stood at -$328537.0 in 2021, then surged by 99.96% to -$135.0 in 2022, then surged by 55655.56% to $75000.0 in 2023, then increased by 5.17% to $78874.0 in 2024, then tumbled by 89.78% to $8062.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Capital Expenditures are $8062.0 (Q3 2025), $8877.0 (Q2 2025), and $14650.0 (Q1 2025).